Management of Vulvar Irritation and Dermatologic Conditions

Diagnostic Approach

The American College of Obstetricians and Gynecologists recommends distinguishing between infectious causes and inflammatory dermatoses, as treatment strategies differ fundamentally between these categories, with vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis being common infectious causes 1
The Centers for Disease Control and Prevention suggests that vulvovaginal candidiasis is characterized by pruritus, vulvovaginal erythema, white discharge, normal vaginal pH (<4.5), and visualization of yeasts/pseudohyphae on wet mount or KOH prep 1
The American Academy of Family Physicians recommends that trichomoniasis is diagnosed based on diffuse malodorous yellow-green discharge with vulvar irritation, though some patients have minimal symptoms 2
The American College of Obstetricians and Gynecologists states that bacterial vaginosis is characterized by vaginal discharge with fishy odor, elevated pH (>4.5), and clue cells on microscopy 2

The Centers for Disease Control and Prevention recommends first-line treatment for uncomplicated vulvovaginal candidiasis with either fluconazole 150 mg oral single dose or short-course topical azole therapy (1-3 days), with cure rates of 80-90% 1
The American College of Obstetricians and Gynecologists suggests that specific topical options for vulvovaginal candidiasis include clotrimazole 1% cream 5g intravaginally for 7-14 days, miconazole 2% cream 5g intravaginally for 7 days, and terconazole 0.8% cream 5g intravaginally for 3 days 1
The American Academy of Family Physicians recommends that patients with trichomoniasis should be treated with oral metronidazole, achieving 90-95% cure rates 2
The American College of Obstetricians and Gynecologists states that pregnant women with vulvovaginal candidiasis should receive only topical azoles for 7 days, as oral agents are contraindicated 2, 1
The American Academy of Family Physicians suggests that recurrent vulvovaginal candidiasis (≥4 episodes/year) requires longer initial therapy followed by maintenance regimen for 6 months 2, 1

The American College of Obstetricians and Gynecologists recommends that recurrent vulvovaginal candidiasis requires maintenance antifungal regimens (clotrimazole, fluconazole, or others) continued for 6 months 2
The Centers for Disease Control and Prevention states that evaluation for predisposing conditions such as diabetes, immunosuppression, HIV, and antibiotic use is necessary for long-term management 1, 3